of life and health for
Indians by enhancing
access to innovative
technologies? Should
access to latest top-of-
the-line technologies
in public health not
be a priority? How
could measures such
as price-control
be assumed to
bolster innovative
technologies when they
can potentially shrink
the ability to pay for
those innovations? The
people of this country
deserve access to
safe and long-lasting
healthcare services,
with due cognizance
of the importance
of quality medical
devices, much as our
soldiers deserve a
safer mechanism to
guard our borders.
Supplementing price-
control policies in the
healthcare framework
with sustained support
to innovation and R&D
is the crying need of
the hour.
The medical device
pricing framework
needs to be
approached in a
segmented manner,
with the object of
providing the right
BIOVOICENEWS.COM
47